CSBR vs MS · P/E 16, rev $56.9M vs P/E 20, $344.27B cap
Champions Oncology Inc (CSBR) versus Morgan Stanley (MS) — a side-by-side from cached financials, not a winner call.
Champions Oncology Inc (CSBR) is a biotechnology company listed on US.
Morgan Stanley (MS) is a capital markets company listed on US. It is led by Ted Pick.
Latest reported CSBR revenue for 2025-04-30 was $56.9M. Net income was $4.7M. CSBR currently screens at market cap $99.8M and trailing P/E 16.0.
MS does not have a complete income-statement cache yet.
CSBR currently screens at market cap $99.8M and trailing P/E 16.0. MS currently screens at market cap $344.27B and trailing P/E 19.8.
Not investment advice. Open the CSBR and MS stock pages for the full models.
Not investment advice.